| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 100,123 | 58,419 | 44,358 | 38,213 | | Cost of Revenue | 77,755 | 53,341 | 41,659 | 44,676 | | | Gross Profit | 22,368 | 5,078 | 2,699 | (6,463) | | | Operating Expenses | | Research Development | 10,059 | 7,575 | 3,154 | (4,824) | | Selling General and Administrative | 29,864 | 19,043 | 13,206 | 9,854 | | Non Recurring | 914 | (17,491) |
-
| (17,519) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (18,469) | (4,049) | (13,661) | 6,026 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 729 | 1,175 | 102 | (418) | | Earnings Before Interest And Taxes | (17,740) | (2,874) | (13,559) | 5,608 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (17,740) | (2,874) | (13,559) | 5,608 | | Income Tax Expense | 62 | (2,277) | 35 | 2,209 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (17,802) | (597) | (13,594) | 3,399 | | | Non-recurring Events | | Discontinued Operations | 180 | (217) | 197 | (22,941) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,622) | (814) | (13,397) | (19,542) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($17,622) | ($814) | ($13,397) | ($19,542) |
|
0.31% Nasdaq 
0.05%
Income Statement
